December 17, 2021
(from left) CDMO Business Head Kohei Murashima, President Ryuichi Kume, and Executive Vice President Yoshihiro Furuya Shionogi Pharma aims at sales of 10 billion yen in its CDMO business in FY2022. It previously planned to achieve this target in FY2024,...read more